Composition: Culture of the vaccine strain Brucella melitensis, biovar Melitensis, Rev-1-1.5-2.0 х109 CFU with the addition of a protective medium consisting of sucrose 10% and gelatin 1.5%. Composition of the sterile solvent includes: potassium hydrogen phosphate, sodium hydrogen phosphate dihydrate, sodium chloride, disodium edetate, indicator «Patent Blue V» (E-131) (LGC, Germany), water for injection.
Indication: For active immunization of sheep and goats against brucellosis caused by Brucella melitensis and for the prevention of epididymitis in sheep caused by Brucella ovis.
Pharmaceutical form: Freeze-dried.
Administration: Conjunctival use.
Dosage: Eanling are vaccinated at the age of 3 to 6 months. The adult herd is vaccinated 2 months before insemination, after preliminary serological tests for brucellosis. Using a dosing pipette-applicator, the prepared vaccine is instilled into the lower conjunctival sac of the animal's eye in the amount of one drop (1 drop ≈ 35-40 μl).
Package:Vaccine is produced in vials of 1.0 ml (25 doses) and 2.0 ml (50 doses).Solvent «Patent Blue V»(E-131) (LGC, Germany), produced in vials of 1.0 ml (25 doses) and 2.0 ml (50 doses) - 1 vial; Dispensing pipette - applicator (sterile) - 1 piece.
Storage conditions: Vaccine should be stored and transported at a temperature of 2 ° C to 8 ° C in a dark place. Do not freeze.